The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cancer statistics, 2015
Open accessAbstract
Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. During the most recent 5 years for which there are data (2007‐2011), delay‐adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women. The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%. However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%). For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress. Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2015;65:5–29. © 2015 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Ezzati, M., Friedman, A. B., Kulkarni, S. C., & Murray, C. J. L. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050066 · Cited by 346
Holford, T. R., Meza, R., Warner, K. E., Meernik, C., Jeon, J., Moolgavkar, S. H., & Levy, D. T. (2014) · JAMA · doi:10.1001/jama.2013.285112 · Cited by 317 · cited 1×
“trol efforts adopted in the wake of the first Surgeon General’s report on smoking and health in 1964 have resulted in 8 million fewer premature smoking-related deaths, one-third of which are due to cancer.(50,51) Death rates for female breast”
Cited by
Items 101–132 of 132
Qiu, S., & Jiang, C. (2019) · European Journal of Nutrition · doi:10.1007/s00394-018-1853-4 · Cited by 53
Engebretson, A., Matrisian, L., & Thompson, C. (2015) · Pancreatology · doi:10.1016/j.pan.2015.05.471 · Cited by 49
Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models
Skobowiat, C., Oak, A. S. W., Kim, T.-K., Yang, C. H., Pfeffer, L. M., Tuckey, R. C., & Slominski, A. T. (2017) · Oncotarget · doi:10.18632/oncotarget.14193 · Cited by 44
Wu, D., Wang, C., Yang, J., Wang, H., Han, H., Zhang, A., Yang, Y., & Li, Q. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00702 · Cited by 45
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Sato-Dahlman, M., Miura, Y., Huang, J. L., Hajeri, P., Jacobsen, K., Davydova, J., & Yamamoto, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18340 · Cited by 43
Lin, Y.-T., Liu, Y.-N., Wu, S.-G., Yang, J. C.-H., & Shih, J.-Y. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.12.014 · Cited by 43
ORLANDO, A., LINSALATA, M., & RUSSO, F. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3463 · Cited by 38
The impact of metformin use on survival in kidney cancer patients with diabetes: A meta-analysis
Li, Y., Hu, L., Xia, Q., Yuan, Y., & Mi, Y. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1548-4 · Cited by 38
miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
Chen, M., Li, D., Gong, N., Wu, H., Su, C., Xie, C., Xiang, H., Lin, C., & Li, X. (2017) · Oncotarget · doi:10.18632/oncotarget.17677 · Cited by 35
Cytotoxicity and bacterial membrane destabilization induced by Annona squamosa L. extracts
PINTO, N. C. C., SILVA, J. B., MENEGATI, L. M., GUEDES, M. C. M. R., MARQUES, L. B., SILVA, T. P. D., MELO, R. C. N. D., SOUZA-FAGUNDES, E. M. D., SALVADOR, M. J., SCIO, E., et al. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720150702 · Cited by 35
Yuan, Y., Hu, Y., Cheng, J.-X., & Ding, P. (2019) · Journal of International Medical Research · doi:10.1177/0300060519878014 · Cited by 33
Chuang, M.-C., Yang, Y.-H., Tsai, Y.-H., Hsieh, M.-J., Lin, Y.-C., Lin, C.-K., Chen, P.-C., & Yang, T.-M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191129 · Cited by 29
Hou, Y.-C., Hu, Q., Huang, J., Fang, J.-Y., & Xiong, H. (2017) · Oncotarget · doi:10.18632/oncotarget.13633 · Cited by 29
Zang, T., Tamae, D., Mesaros, C., Wang, Q., Huang, M., Blair, I. A., & Penning, T. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.08.001 · Cited by 29
Design of a Culturally-Informed Virtual Human for Educating Hispanic Women about Cervical Cancer
Mendu, S., Boukhechba, M., Gordon, J. R., Datta, D., Molina, E., Arroyo, G., Proctor, S. K., Wells, K. J., & Barnes, L. E. (2018) · Proceedings of the 12th EAI International Conference on Pervasive Computing Technologies for Healthcare · doi:10.1145/3240925.3240968 · Cited by 28
Su, L., & Liu, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8669 · Cited by 27
Frame, M. C., & Serrels, A. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.013 · Cited by 23
Li, Q., Yang, T., Li, D., Ding, F., Bai, G., Wang, W., & Sun, H. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0162 · Cited by 26
Prognostic value of chemotherapy-induced neutropenia at the first cycle in invasive breast cancer
Ma, R.-M., Chen, C.-Z., Zhang, W., You, J., Huang, D.-P., & Guo, G.-L. (2016) · Medicine · doi:10.1097/md.0000000000003240 · Cited by 23
Han, H., Zhan, Z., Xu, J., & Song, Z. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s210619 · Cited by 21
Prognostic relevance of Src activation in stage II-III colon cancer
Martínez-Pérez, J., Lopez-Calderero, I., Saez, C., Benavent, M., Limon, M. L., Gonzalez-Exposito, R., Soldevilla, B., Riesco-Martínez, M. C., Salamanca, J., Carnero, A., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.05.025 · Cited by 20
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act
Lubberts, S., Meijer, C., Demaria, M., & Gietema, J. A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102963 · Cited by 19
Dengsø, K. E., Thomsen, T., Andersen, E. W., Hansen, C. P., Christensen, B. M., Hillingsø, J., & Dalton, S. O. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06251-4 · Cited by 19
Sun, D.-C., Shi, Y., Wang, Y.-R., Lv, Y., Yan, H., Mao, H., Wang, Z.-K., Wu, Z.-Y., Shi, W.-W., & Dai, G.-H. (2017) · Scientific Reports · doi:10.1038/s41598-017-14669-2 · Cited by 16
Zhong, M., Goh, P. H., Li, D., Bao, J., & Xu, W. (2020) · Journal of Health Psychology · doi:10.1177/1359105317736576 · Cited by 14
Shrestha, K. R., Jeon, S. H., Jung, A. R., Kim, I. G., Kim, G. E., Park, Y. H., Kim, S. H., & Lee, J. Y. (2019) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-019-00187-x · Cited by 14
Usability and acceptance evaluation of ACESO: a Web-based breast cancer survivorship tool
Kapoor, A., & Nambisan, P. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0670-8 · Cited by 12
Bauml, J., Kim, J., Zhang, X., Aggarwal, C., Cohen, R. B., & Schmitz, K. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0604-5 · Cited by 10
Dehghani, M., Samani, Z., Abidi, H., Manzouri, L., Mahmoudi, R., Hosseini Teshnizi, S., & Nikseresht, M. (2018) · International Journal of Genomics · doi:10.1155/2018/4863757 · Cited by 9
Lei, Y., Zhang, B., Zhang, Y., Zhao, Y., Sun, J., Zhang, X., & Yang, S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3603 · Cited by 8
Lu, J., Duan, Y., Liu, P., He, X., Yang, Y., Zhang, R., & Weng, L. (2023) · The Journal of Pathology · doi:10.1002/path.6015 · Cited by 6
Aydin, A., & Gürsoy, A. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08819-2 · Cited by 5
Metadata
- Authors
- Siegel, R. L., Miller, K. D., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 65
- Issue
- 1
- Pages
- 5-29
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2170552969
- Cited by
- 11,853
- References
- 3
- FWCI
- 1102.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
